Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$7.08 - $19.4 $91,643 - $251,113
-12,944 Reduced 22.75%
43,952 $409,000
Q4 2022

Feb 14, 2023

SELL
$8.94 - $18.35 $119,053 - $244,366
-13,317 Reduced 18.97%
56,896 $1.04 Million
Q3 2022

Nov 08, 2022

BUY
$6.12 - $9.5 $30,612 - $47,519
5,002 Added 7.67%
70,213 $655,000
Q2 2022

Aug 15, 2022

BUY
$4.7 - $7.22 $306,491 - $470,823
65,211 New
65,211 $392,000

Others Institutions Holding CVRX

About CVRx, Inc.


  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $355M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.